欧盟评估非转基因曲霉菌株DEA 56-111生产的腺苷酸脱氨酶的安全?/h1>
放大字体缩小字体时间?024-04-12 11:45 来源:食品伙伴网 作者: 泽夕
核心提示?024??0日,欧盟食品安全局就一种腺苷酸脱氨酶(AMP deaminase)的安全性评价发布意见、/div>
   食品伙伴网讯2024??0日, 欧盟食品安全局就一种腺苷酸 脱氨酵/a>(AMP deaminase)的安全性评价发布意见
  据了解,这种食品酶是田a href='//www.sqrdapp.com/news/tag_462.html' class='zdbq' title='非转基因相关食品资讯' target='_blank'>非转基因 曲霉菋/a>株DEA 56-111生产的,旨在用于酵母和酵母产品的加工、/div>
  经过评估,专家小组认为,在预期的使用条件下,不能排除饮食暴露引起过敏反应的风险,但这种可能性被认为很低。根据所提供的数据,评估小组得出结论,这种食品酶在预期使用条件下不会引起安全问题。部分原文报道如下:
  The food enzyme AMP deaminase (AMP aminohydrolase; EC 3.5.4.6) is produced with the non-genetically modified microorganism Aspergillus sp. strain DEA 56-111 by Shin Nihon Chemical Co., Ltd. The food enzyme was co nsidered free from viable cells of the production organism. It is intended to be used in the processing of yeast and yeast products. Dietary exposure to the food enzyme-total organic solids (TOS) was estimated to be up to 0.005 mg TOS/kg body weight (bw) per day in European populations. Genotoxicity tests did not indicate a safety concern. The Panel identified a no observed adverse effect level of 1984 mg TOS/kg bw per day, the highest dose tested, which, when compared with the estimated dietary exposure, resulted in a margin of exposure of at least 396,800. A search for the similarity of the amino acid sequence of the food enzyme to known allergens was made and no match was found. The Panel co nsidered that the risk of allergic reactions upon dietary exposure cannot be excluded, but the likelihood is low. ba sed on the data provided, the Panel co ncluded that this food enzyme does not give rise to safety concerns, under the intended co nditions of use.
   本文由食品伙伴网食品资讯中心编辑,有任何疑问,请联系news@www.sqrdapp.com、/span>
日期9a href="//www.sqrdapp.com/news/2024-04-12.html">2024-04-12
[ 食品资讯搜索] [ 加入收藏] [ 告诉好友] [ 打印本文] [ 关闭窗口]

Baidu
map